Table 1.
Descriptive statistics of demographic and tumor characteristics (n = 105).
| Total (n = 105) | TOP (n = 67) | COP (n = 38) | Difference in means (95% CI) | |
|---|---|---|---|---|
| Age (yrs), mean (SD), range | 35.0 (5.3), 17–45 | 34.2 (5.1), 17–44 | 32.3 (5.6), 23–45 | 1.8 (−0.2 to 4.0) |
| Gravida, mean (SD), range | 3.6 (1.7), 1–9 | 3.8 (1.6), 1–8 | 3.2 (1.9), 1–9 | 0.6 (−0.4 to 1.3) |
| Para, mean (SD), range | 1.3 (1.2), 0–7 | 1.4 (1.0), 0–5 | 1.3 (1.5), 0–7 | 0.1 (−0.3 to 0.6) |
| GA at diagnosis (wks), mean (SD), range | 20.0 (11.1), 5–41 | 14.8 (7.7), 5–31 | 30.8 (8.5), 6–41 | −16.0 (−19.3 to −12.8)* |
| Method of disease detection, n (%) | ||||
| Bleeding | 90 (85.7) | 57 (85.1) | 33 (86.8) | −1.8 (−14.6 to 13.9) |
| Physical examination | 8 (7.6) | 4 (6.0) | 4 (10.5) | −4.6 (−18.6 to 6.0) |
| Abnormal cervical cancer screening | 7 (6.7) | 6 (8.9) | 1 (2.6) | 6.3 (−5.6 to 15.8) |
| FIGO Stage, n (%) | ||||
| IA | 7 (6.7) | 3 (4.5) | 4 (10.5) | −6.1 (−20.0 to 4.1) |
| IB1 | 30 (28.6) | 19 (28.4) | 11 (28.9) | −0.6 (−19.0 to 16.2) |
| IB2 | 33 (31.4) | 26 (38.8) | 7 (18.4) | 20.4 (1.9 to 35.5)* |
| II | 28 (26.6) | 17 (25.4) | 11 (28.9) | −3.6 (−21.7 to 13.1) |
| III–IV | 7 (6.7) | 2 (3.0) | 5 (13.2) | −10.2 (−24.5 to 0.2) |
| Pathological type, n (%) | ||||
| Squamous cell carcinoma | 83 (79.1) | 53 (79.1) | 30 (78.9) | 0.16 (−14.8 to 17.4) |
| Adenocarcinoma | 16 (15.2) | 10 (14.9) | 6 (15.8) | −0.9 (−16.9 to 12.5) |
| Other type† | 6 (5.7) | 4 (6.0) | 2 (5.3) | 0.7 (−11.8 to 9.9) |
| Tumor size, n (%) | ||||
| ≤4 cm | 46 (43.8) | 30 (44.8) | 16 (42.1) | 2.7 (−16.7 to 21.2) |
| >4 cm | 59 (56.2) | 37 (55.2) | 22 (57.9) | −2.7 (−21.2 to 16.7) |
TOP, termination of pregnancy; COP, continuation of pregnancy; GA, gestational age; yrs, years; wks, weeks.
*
P < 0.01.
†
Three cases of small cell carcinoma, one case of poorly differentiated carcinoma, one case of cervical sarcoma, and one case of neuroendocrine carcinoma.